Project Grant K23MH140069
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $818,253 to The Regents of the University of California, San Francisco under the Mental Health Research Grants program (CFDA 93.242) beginning July 1, 2025, and extending through April 30, 2030. This Project Grant supports a five-year research investigation examining neuromodulatory system abnormalities in late-life depression (LLD), with specific focus on the associations between structural and functional brain...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $394,200 to the Research Foundation For Mental Hygiene, Inc. (through its New York State Psychiatric Institute division) under the Mental Health Research Grants program (CFDA 93.242) on August 1, 2025, for a five-year project period extending through July 31, 2030. This Project Grant funds a clinical research study examining the role of the anterior hippocampus in major depressive disorder (MDD) pathogenesis....
- Federal Grant Award Summary The Laureate Institute for Brain Research, Inc. received a $514,178 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective July 1, 2025, through April 30, 2030. The award funds a five-year research initiative investigating the mechanistic relationships between brain circuits and negative valence system behaviors in treatment-resistant depression (TRD) using low-intensity...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded McLean Hospital a $777,016 Project Grant under the Mental Health Research Grants program (CFDA 93.242) effective July 1, 2025, through April 30, 2030. This research project investigates the synaptic mechanisms of continuous theta burst stimulation (cTBS), an FDA-cleared repetitive transcranial magnetic stimulation (rTMS) protocol used to treat treatment-resistant depression. The primary deliverables include...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Washington University a Project Grant totaling $284,333 under the Mental Health Research Grants program (CFDA 93.242) on August 4, 2025, for research on mechanism-based dose titration strategies to modify brain electrophysiology during antidepressant therapy for treatment-resistant depression (TRD). The research will be conducted through June 30, 2029, and focuses on developing personalized medicine approaches...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Leland Stanford Junior University a $1,066,793 Project Grant under the Mental Health Research Grants program (CFDA 93.242) effective April 1, 2026, with a completion date of January 31, 2028. This research initiative, titled "Early TMS-EEG Potentials as Biomarkers for Personalized Neuromodulation in Treatment-Resistant Depression," develops and validates a personalized intermittent theta-burst...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Leland Stanford Junior University a Project Grant totaling $192,192.00 (CFDA 93.242, Mental Health Research Grants) beginning April 15, 2026, and concluding March 31, 2031. This award supports the development of an artificial intelligence foundation model designed to advance the understanding and treatment of Major Depressive Disorder (MDD) through functional neuroimaging analysis. The project leverages...
- Federal Project Grant Award Summary Vanderbilt University received a $217,818 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded September 9, 2025, with a completion date of September 8, 2027. The award funds research investigating metabotropic glutamate receptor (mGlu) signaling, specifically Group III mGlu4/7 receptors, as potential therapeutic targets for modulating glutamatergic synaptic transmission in...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Alabama at Birmingham a $409,750 Project Grant under the Mental Health Research Grants program (CFDA 93.242) on March 15, 2026, with completion targeted for March 14, 2028. This award funds fundamental neuroscience research investigating the role of localized dopamine signals in learning and neural circuit modulation. The primary deliverables include empirical findings on dopamine's mechanisms of...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a $728,751 Project Grant to the University of Pittsburgh under the Mental Health Research Grants program (CFDA 93.242) for the five-year period from April 1, 2026 through March 31, 2031. The funded research, titled "Dissecting Antidepressant Placebo Expectancy-Mood Dynamics," will investigate the causal neural mechanisms underlying antidepressant placebo effects in patients with major depressive disorder...
Vanderbilt University Medical Center received $186,624 in project grant funding from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded May 1, 2026, with completion targeted for April 30, 2031. This research project addresses cognitive enhancement in recurrent late-life depression through a randomized clinical trial pilot study. The project will deliver evidence-based investigation of a multi-modal cognitive-enhancing intervention combining targeted cognitive training (TCT) specifically designed for executive function deficits with transcranial direct current stimulation (tDCS) applied to the frontal lobes. The study will enroll sixty non-demented older adults with executive dysfunction and recurrent late-life depression to undergo a four-week daily intervention across three randomized conditions, generating cognitive and neural outcome data on executive functioning and executive control network brain connectivity. The research products generated through this award will include empirical findings on whether the stepwise engagement of the executive control network differs significantly across randomized intervention groups, thereby advancing understanding of neuroplasticity-promoting interventions for older adults experiencing cognitive impairment associated with recurrent depression. This work addresses a critical gap in treatment approaches for late-life depression, as executive dysfunction persists despite symptom remission and correlates with increased risk of cognitive decline and dementia progression. Study outcomes will contribute to the evidence base for optimizing combined cognitive and neuromodulation interventions in this vulnerable population.Summary of Federal Grant Award
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $186.6k | 5/1/26 |